These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 23421781

  • 1. Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial.
    Chang AB, Grimwood K, Wilson AC, van Asperen PP, Byrnes CA, O'Grady KA, Sloots TP, Robertson CF, Torzillo PJ, McCallum GB, Masters IB, Buntain HM, Mackay IM, Ungerer J, Tuppin J, Morris PS.
    Trials; 2013 Feb 20; 14():53. PubMed ID: 23421781
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial.
    Goyal V, Grimwood K, Byrnes CA, Morris PS, Masters IB, Ware RS, McCallum GB, Binks MJ, Marchant JM, van Asperen P, O'Grady KF, Champion A, Buntain HM, Petsky H, Torzillo PJ, Chang AB.
    Lancet; 2018 Oct 06; 392(10154):1197-1206. PubMed ID: 30241722
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial.
    Goyal V, Grimwood K, Ware RS, Byrnes CA, Morris PS, Masters IB, McCallum GB, Binks MJ, Smith-Vaughan H, O'Grady KF, Champion A, Buntain HM, Schultz A, Chatfield M, Torzillo PJ, Chang AB.
    Lancet Respir Med; 2019 Sep 06; 7(9):791-801. PubMed ID: 31427252
    [Abstract] [Full Text] [Related]

  • 5. Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial.
    Valery PC, Morris PS, Grimwood K, Torzillo PJ, Byrnes CA, Masters IB, Bauert PA, McCallum GB, Mobberly C, Chang AB.
    BMC Pediatr; 2012 Aug 14; 12():122. PubMed ID: 22891748
    [Abstract] [Full Text] [Related]

  • 6. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial.
    Valery PC, Morris PS, Byrnes CA, Grimwood K, Torzillo PJ, Bauert PA, Masters IB, Diaz A, McCallum GB, Mobberley C, Tjhung I, Hare KM, Ware RS, Chang AB.
    Lancet Respir Med; 2013 Oct 14; 1(8):610-620. PubMed ID: 24461664
    [Abstract] [Full Text] [Related]

  • 7. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.
    Wong C, Jayaram L, Karalus N, Eaton T, Tong C, Hockey H, Milne D, Fergusson W, Tuffery C, Sexton P, Storey L, Ashton T.
    Lancet; 2012 Aug 18; 380(9842):660-7. PubMed ID: 22901887
    [Abstract] [Full Text] [Related]

  • 8. Duration of amoxicillin-clavulanate for protracted bacterial bronchitis in children (DACS): a multi-centre, double blind, randomised controlled trial.
    Ruffles TJC, Goyal V, Marchant JM, Masters IB, Yerkovich S, Buntain H, Cook A, Schultz A, Upham JW, Champion A, Versteegh L, Chang AB.
    Lancet Respir Med; 2021 Oct 18; 9(10):1121-1129. PubMed ID: 34048716
    [Abstract] [Full Text] [Related]

  • 9. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial.
    Altenburg J, de Graaff CS, Stienstra Y, Sloos JH, van Haren EH, Koppers RJ, van der Werf TS, Boersma WG.
    JAMA; 2013 Mar 27; 309(12):1251-9. PubMed ID: 23532241
    [Abstract] [Full Text] [Related]

  • 10. Azithromycin for acute lower respiratory tract infections.
    Laopaiboon M, Panpanich R, Swa Mya K.
    Cochrane Database Syst Rev; 2015 Mar 08; 2015(3):CD001954. PubMed ID: 25749735
    [Abstract] [Full Text] [Related]

  • 11. Reducing exacerbations in children and adults with primary ciliary dyskinesia using erdosteine and/or azithromycin therapy (REPEAT trial): study protocol for a multicentre, double-blind, double-dummy, 2×2 partial factorial, randomised controlled trial.
    Chang AB, Morgan LC, Duncan EL, Chatfield MD, Schultz A, Leo PJ, McCallum GB, McInerney-Leo AM, McPhail SM, Zhao Y, Kruljac C, Smith-Vaughan HC, Morris PS, Marchant JM, Yerkovich ST, Cook AL, Wurzel D, Versteegh L, O'Farrell H, McElrea MS, Fletcher S, D'Antoine H, Stroil-Salama E, Robinson PJ, Grimwood K.
    BMJ Open Respir Res; 2022 May 08; 9(1):. PubMed ID: 35534039
    [Abstract] [Full Text] [Related]

  • 12. Azithromycin for acute lower respiratory tract infections.
    Panpanich R, Lerttrakarnnon P, Laopaiboon M.
    Cochrane Database Syst Rev; 2004 Oct 18; (4):CD001954. PubMed ID: 15497172
    [Abstract] [Full Text] [Related]

  • 13. A randomized controlled trial of azithromycin and amoxycillin/clavulanate in the management of subacute childhood rhinosinusitis.
    Ng DK, Chow PY, Leung L, Chau KW, Chan E, Ho JC.
    J Paediatr Child Health; 2000 Aug 18; 36(4):378-81. PubMed ID: 10940175
    [Abstract] [Full Text] [Related]

  • 14. Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trial.
    O'Grady KA, Grimwood K, Cripps A, Mulholland EK, Morris P, Torzillo PJ, Wood N, Smith-Vaughan H, Revell A, Wilson A, Van Asperen P, Richmond P, Thornton R, Rablin S, Chang AB.
    Trials; 2013 Sep 05; 14():282. PubMed ID: 24010917
    [Abstract] [Full Text] [Related]

  • 15. Azithromycin for acute lower respiratory tract infections.
    Panpanich R, Lerttrakarnnon P, Laopaiboon M.
    Cochrane Database Syst Rev; 2008 Jan 23; (1):CD001954. PubMed ID: 18253999
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of amoxycillin versus amoxycillin/clavulanate in acute exacerbations of chronic pulmonary obstructive disease in primary care.
    Llor C, Hernández S, Ribas A, Alvarez C, Cots JM, Bayona C, González I, Miravitlles M, BRAMOX Study Group.
    Int J Chron Obstruct Pulmon Dis; 2009 Jan 23; 4():45-53. PubMed ID: 19436696
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Randomised controlled trial of amoxycillin clavulanate in children with chronic wet cough.
    Marchant J, Masters IB, Champion A, Petsky H, Chang AB.
    Thorax; 2012 Aug 23; 67(8):689-93. PubMed ID: 22628120
    [Abstract] [Full Text] [Related]

  • 19. Bronchiectasis - Exercise as Therapy (BREATH): rationale and study protocol for a multi-center randomized controlled trial.
    Jones T, O'Grady KF, Goyal V, Masters IB, McCallum G, Drovandi C, Lung T, Baque E, Brookes DSK, Terranova CO, Chang AB, Trost SG.
    Trials; 2022 Apr 11; 23(1):292. PubMed ID: 35410363
    [Abstract] [Full Text] [Related]

  • 20. Phenotypic Features of Pediatric Bronchiectasis Exacerbations Associated With Symptom Resolution After 14 Days of Oral Antibiotic Treatment.
    Goyal V, Yerkovich ST, Grimwood K, Marchant JM, Byrnes CA, Masters IB, Chang AB.
    Chest; 2023 Dec 11; 164(6):1378-1386. PubMed ID: 37437879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.